News & Opinion
The latest developments in cannabis.
Report Launch: The Social Impact of Cannabis Legalisation
Hanway Associates is proud to launch ‘The Social Impact of Cannabis Legalisation: How cannabis reform can shape lives, livelihoods and the law’.
Report Launch: Recreational Europe
This once-hypothetical scenario is fast becoming a reality. European cannabis reform has become a question of how, not if.
EU court rules that CBD is not a narcotic
A ruling from the European Court of Justice (CJEU) opens up the French market for CBD, and sets the stage for a regulatory U-turn from the European Commission on novel foods.
CROP17 Partnership with Savills and CambridgeHOK
Hanway teams up with Savills and CambridgeHOK to help British farmers, food companies and landowners capitalise on medical cannabis opportunities.
CBD: Medicine, Food, Cosmetic, E-liquid? A risk-based approach to regulation
With its wide array of uses, who should be regulating a substance with as many facets at CBD?
Cannabis. Canada. What Does This Mean for Europe?
In a historic event that will be closely watched across the world, Canada today becomes the first G7 country to legalise cannabis for recreational use.
Cannabis Europa Conferences Will Plot the Path for Europe’s Medical Cannabis Industry
Cannabis Europa Paris will take place on 8 February 2019, and Cannabis Europa London will take place on the 24-25 June 2019.
Membership of French Committee on Medical Cannabis Announced | Pierre-Yves Galléty
The French Agency for Medicines and Healthcare Products Safety (ANSM) has published the list of the members who will make up the Special Committee charged with the review of medical cannabis benefits in France.
UK Government Announces Definition For Cannabis-Based Medicines
On September 21st the UK government announced how they would define cannabis-based products for medicinal use. Following the conclusion of the two part review by the Chief Medical Officer and the ACMD on July 25th, Home Secretary Sajid Javid committed to swift action on the matter, and promised that these products would be lawful by autumn.
French Launch Committee to Review Medical Cannabis | Pierre-Yves Galléty
On Monday 10th September, the National Agency for Health and Medicines (ANSM) announced the creation of a special committee to review the evidence supporting the effectiveness of medical cannabis.
Industry Leaders Gather in London to Discuss the Future of European Medical Cannabis
Over the next 6 ½ weeks in the build up to the conference we will be making a series of exciting announcements including a raft of new speakers, sponsors and events.
[Lift] George McBride - Canadian Cannabis in Europe – Challenges and Opportunities
Canada has a unique opportunity in emerging European medical cannabis markets. However, Europe is a complex patchwork of challenges and opportunities that only the most astute will be able to successfully capitalise on.